Search All HTA Publications

CADTH.ca only Canadian HTA websites What is this?

1. Recombinant Activated Factor VII for Prevention of Bleeding Unrelated to Hemophilia: Clinical and Economic Systematic Review

   February 4, 2010

   CADTH’s health technology assessment report examines the clinical efficacy and cost-effectiveness of off-label use of recombinant activated factor VII (rFVIIa), an agent currently approved to control bleeding in patients with either hemophilia A or B and clotting factor inhibitors. &nb...

   View Summary

2. H1N1 and Seasonal Influenza Vaccine Practices across Canadian Jurisdictions: Issue 6

   December 23, 2009

     Download this report Context Objective  Findings Knowledge Gaps Conclusion References Context The delivery of influenza vaccination programs in 2009 required rapid planning and implementation. Considerable uncertainty arose regarding the timing of H1N1 and seasonal ...

   View Summary

3. Clopidogrel versus Other Antiplatelet Agents in the Secondary Prevention of Vascular Events in Adults with Cerebrovascular Disease: Clinical and Cost-Effectiveness Analyses

   December 22, 2009

   CADTH’s health technology assessment report on clopidogrel versus other antiplatelet agents examines the clinical efficacy and cost-effectiveness of this treatment strategy for secondary prevention of vascular events in adults with cerebrovascular disease. The report also assesses cur...

   View Summary

4. Addendum to the Canadian Agency for Drugs and Technologies in Health Guidelines for the Economic Evaluation of Health Technologies: Specific Guidance for Oncology Products

   December 22, 2009

   This addendum to CADTH’s Guidelines for the Economic Evaluation of Health Technologies (3rd Edition) is intended to provide specific guidance on the methods used to conduct high-quality economic evaluations of oncology products. The oncology-specific guidelines should be considered a comp...

   View Summary

5. Portable Monitoring Devices for Diagnosis of Obstructive Sleep Apnea at Home: Review of Accuracy, Cost-Effectiveness, Guidelines, and Coverage in Canada

   December 9, 2009

   An amendment to this report to reflect the inclusion of additional portable monitoring devices that are licensed in Canada has been made. The revised report is now available. View Report (38 pages) View Executive Summary (3 pages) Context and Policy Issues Obstructive sleep apnea...

   View Summary

6. Health Technology Update Issue 12

   December 8, 2009

   Download the PDF version This issue of Health Technology Update features a new application of an old tool for diabetes screening and diagnosis. This issue also provides insight into activity-based funding and provincial interest in this payment model as a way to sustain health care budgets. Addi...

   View Summary

7. Reassessment of Health Technologies: Obsolescence and Waste

   December 4, 2009

   CADTH’s report on the reassessment of health technologies is intended to inform and encourage further discussion about the appropriate use of existing health technologies. This report considers practical and policy issues related to health technology obsolescence and proposes a framework f...

   View Summary

8. Implications of ISO Certification and Licensing of Patient Management Software: Issue 5

   November 25, 2009

   In This Issue

   • Context
   • Objective
   • Findings
   • Knowledge Gaps
   • Conclusion
   • References

9. The Location of High-Intensity Focused Ultrasound Facilities in Canada for the Treatment of Prostate Cancer and Access to Treatment - Issue 4

   November 18, 2009

10. Carbon Ion Radiation Therapy - Issue 3

    November 13, 2009